| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |